EU-funded projects

IDF Europe welcomes the opportunity to take an active role in EU funded projects that aim at improving the health of European citizens, as these contribute to finding new treatments for diabetes and improving the lives of people living with this condition.

Developed within the EU Seventh Framework Programme (FP7) and Horizon 2020 research and innovation programme, these projects encourage the development and validation of new therapies, methods for health promotion and prevention, as well as sustainable and efficient healthcare systems. IDF Europe is currently involved in the following projects: EuRhythdia, ePredice and Feel4diabetes, with Eurocondor and Manage Care having just concluded.

EuRhythDia - Lifestyle and diabetes

Evidence has accumulated that disruption of our body’s internal clock (the so-called circadian clock) might contribute to the development of Type 2 diabetes and other cardiometabolic complications.

Few studies have investigated the link between the disruption of the daily sleep-wake pattern and Type 2 diabetes in man. For this reason, a multi-disciplinary consortium of leading academic experts and research-intensive SME’s have joined forces under EuRhythDia, the Consortium on chronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population. This 5-year project will look at whether lifestyle change to reset the internal clock can significantly reduce the risk of developing Type 2 diabetes and cardiometabolic complications. For more information, please visit

Principal investigator: Prof Rainer Böger

ePredice - Early prevention

ePredice, the Consortium for the Early Prevention of Diabetes Complications in Europe, unites 32 European academics, public healthcare professionals and SMEs with the aim to assess the effects of various medical treatments and lifestyle interventions on different microvascular complications affecting people with intermediate hyperglycaemia and screen-detected Type 2 diabetes.

This research project comes at a time where new treatments for the early prevention of diabetes complications are increasingly needed. Type 2 diabetes and Impaired Glucose Tolerance (IGT) are the major cause for morbidity and mortality due to associated complications in Europe. The economic burden is steadily rising and, with poor quality of life for people with diabetes due to chronic treatment and multiple complications, early prevention could substantially reduce the socio-economic burden of diabetes in Europe. For more information, please visit

Co-Principal investigators: Prof Jaakko Tuomilehto and Prof Rafael Gabriel


Feel4diabetes (Families across Europe following a healthy lifestyle 4 diabetes prevention) is a EU-funded project aiming to develop, implement and evaluate an evidence-based and potentially cost-effective and scalable intervention programme to prevent type 2 diabetes across Europe, primarily focusing on families from vulnerable groups. The project spans the period 2014 to 2019 and is carried out by a multidisciplinary team of 10 partners across the EU.
The project focuses on families because risk factors associated with type 2 diabetes tend to cluster within a family given that its members share common genetic background, lifestyle habits, social and physical environment. Promoting healthy behaviours and supportive environmental changes when the family is approached as a whole seems to be more effective compared to targeting the family members individually.

Feel4Diabetes is implemented in two high-income countries (Belgium and Finland), two countries under economic crisis (Greece and Spain) and two low/middle-income countries (Bulgaria and Hungary).

IDF Europe’s role in the project is to facilitate events and workshops for the advisory board and partners and to disseminate activities and results with the aim of embedding the learnings derived from the project into policies and practices at the local, national and international level.

For more information, please visit

Principal investigator: Assoc Prof Dr Yannis Manios

Eurocondor - Preserving eyesight

A group of 17 leading European ophthalmologists and researchers have gathered together under Eurocondor, the European Consortium for the Early Treatment of Diabetic Retinopathy, with the aim of testing a new eye drop treatment that could prevent the development of diabetic retinopathy.

Diabetic retinopathy (DR) –the general term for all eye complications caused by diabetes- is the leading cause of blindness among working-age individuals in developed countries. Current treatments of DR are only indicated in advanced stages of the disease and are intrusive, costly and associated with significant side-effects. For this reason, new non-intrusive pharmacological treatments for the early stages of the disease are needed. Such new treatment could open a new field of research, reduce the socio-economic burden of treating DR, and ultimately improve the lives of people living with diabetes.

The EUROCONDOR project held its 6th and final General Assembly on 22-23 June 2016 at Citylabs facilities in Manchester, U.K.

For more information and the press release, please visit

Principal investigator: Prof Rafael Simó


The MANAGE CARE project, launched in September 2013 at a kick-off meeting, reached its end in May 2016 with a Symposium held at the International Conference on Integrated Care in Barcelona.
Starting with diabetes as a chronic care example, MANAGE CARE’s aim was to develop an innovative chronic care model applicable not only for diabetes, but also for other chronic diseases.
MANAGE-CARE aimed to prevent costly complications and frailty in elderly with type 2 diabetes, enabling them to live independent, healthy and active lives as long as possible. This was achieved by driving innovation and change in the current treatment approach, shifting from diabetes management (disease-specific care trajectory) to chronic care management (non-disease focused model). A roadmap for implementation of the model was developed, providing also guidelines for development of chronic care models in a broader context.
Partners participating in MANAGE CARE included all the leading organisations in Europe in the academic, research and public policy fields, mostly related to diabetes management. The project was led by Prof Peter Schwarz of the University of Dresden. IDF Europe joined the project as leader of the Dissemination Work Package.

A Patient Empowerment Booklet for people with type 2 diabetes is among the deliverables of MANAGE CARE, for which IDF Europe ensured translation into multiple languages. The Bulgarian, English, French, German, Greek, Italian, Polish, Portuguese, Russian and Spanish versions of the Booklet are available here, with more to come.

Other project deliverables will also be available on IDF Europe’s website, as well as the MANAGE CARE’s.

For more information, please visit


Principal investigator: Prof Dr Peter Schwarz

Involvement in other EU-funded projects

IDF Europe has extensive experience in EU funded projects. Here are some links to previous EU funded projects where IDF Europe has been involved in:

  • Renewing Health: European project aiming at implementing large-scale real-life test beds for the validation and evaluation of innovative telemedicine services by means of a patient-centred approach and a common rigorous assessment methodology. Read more.
  • SWEET: a European project to improve secondary prevention, diagnosis and control of type 1 and type 2 diabetes in children and adolescents by supporting the development of centres of reference (CORs) for pediatric and adolescent diabetes services across the EU. Read more.
  • IMAGE: a project aiming at developing and implementing a European Guideline and Training Standards for diabetes prevention.
  • DIAdvisor: a large-scale integrating project (IP) aiming at the development of a prediction based tool which uses past and easily available information to optimise the therapy of type 1 and type 2 diabetes. 
  • DIAMAP: a European project to undertake a wide survey of the current European diabetes research landscape, from which expert opinion can identify gaps and highlight strengths, to guide a Road Map strategy for diabetes research in Europe. Read more.

Joint Action on Chronic Diseases – CHRODIS

The purpose of this Joint Action is to identify, exchange, scale-up and transfer best practices and effective interventions for chronic diseases, with a specific focus on health promotion and prevention, multi-morbidity and diabetes. 

Health   promotion and prevention focuses on behavioural risk factors, social determinants and inequalities in health. Work on multi-morbidity focuses on multi- disciplinary and integrated care, patient safety and professional training. Diabetes is being used as a case study and looks into primary prevention through to treatment, with a specific focus on national diabetes plans.

IDF Europe is specifically involved in Work Package 7 which takes Diabetes as a case study on strengthening health care for people with chronic diseases. WP7 focuses on  aspects  of  primary  prevention,  identification  of  people  at  high  risk,  early  diagnosis,  secondary prevention, and comprehensive multifactorial care (all for type 2 diabetes). There is also an focus on the development of national diabetes plans. A Platform of Knowledge Exchange (PKE) will be develop to house all the best practices identified through the Joint Action.

Click here to get an overview of 2015 activities and planned activities for 2016 across all Joint Action Work Packages.

For more information:

Other project

  • EConDA-Economics of Chronic Diseases: The key aim of the project is to aid EU Member States to develop, select and implement more cost-effective policies to improve chronic disease prevention and impact upon populations with the highest rates of premature deaths from chronic diseases and reduce health inequalities. For more information:


For questions about IDF Europe's involvement in EU-funded projects, please contact [email protected]